CooperCompanies Q1 revenue up 16% to $787M; non-GAAP EPS $3.24

COOPER COMPANIES, INC.

2022-Q1 EPS reported $1.91 revenue$787,200,000

Revenue $787.2M (+16% YoY); CooperVision +11% to $561.5M, CooperSurgical +30% to $225.7M.
GAAP diluted EPS $1.91 (vs $42.31 prior year due to deferred tax benefit); non-GAAP diluted EPS $3.24 (+2%).
Net debt $2,981.5M after Generate Life Sciences acquisition; adjusted leverage 2.71x.
FY2022 guidance: revenue $3,261-$3,329M; non-GAAP EPS $13.70-$14.20.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.